Compare, Analyse Lupin Ltd with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs TEVA PHARMA (Israel) - Comparison Results

LUPIN     Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 LUPIN   TEVA PHARMA
EQUITY SHARE DATA
    LUPIN
Mar-19
TEVA PHARMA
Dec-13
LUPIN/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs9862,973-   
Low Rs7202,582-   
Sales per share (Unadj.) Rs369.51,706.1-  
Earnings per share (Unadj.) Rs13.4106.6-  
Cash flow per share (Unadj.) Rs37.4244.5-  
Dividends per share (Unadj.) Rs093.30-  
Dividend yield (eoy) %03.4 0.0%  
Book value per share (Unadj.) Rs303.71,895.1-  
Shares outstanding (eoy) m452.49848.00-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.31.6 141.8%   
Avg P/E ratio x63.626.1 244.2%  
P/CF ratio (eoy) x22.811.4 200.9%  
Price / Book Value ratio x2.81.5 191.7%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m386,0642,355,388 16.4%   
No. of employees `00017.744.9 39.3%   
Total wages/salary Rs m31,5130-   
Avg. sales/employee Rs Th9,453.832,189.6 29.4%   
Avg. wages/employee Rs Th1,782.00-   
Avg. net profit/employee Rs Th343.02,010.9 17.1%   
INCOME DATA
Net Sales Rs m167,1821,446,763 11.6%  
Other income Rs m3,6400-   
Total revenues Rs m170,8221,446,763 11.8%   
Gross profit Rs m28,822396,197 7.3%  
Depreciation Rs m10,850116,943 9.3%   
Interest Rs m3,07828,417 10.8%   
Profit before tax Rs m18,534250,837 7.4%   
Minority Interest Rs m-891,140 -7.8%   
Prior Period Items Rs m380-   
Extraordinary Inc (Exp) Rs m-3,400-164,661 2.1%   
Tax Rs m9,017-3,062 -294.4%   
Profit after tax Rs m6,06690,378 6.7%  
Gross profit margin %17.227.4 63.0%  
Effective tax rate %48.7-1.2 -3,984.8%   
Net profit margin %3.66.2 58.1%  
BALANCE SHEET DATA
Current assets Rs m138,536977,138 14.2%   
Current liabilities Rs m61,299852,147 7.2%   
Net working cap to sales %46.28.6 534.8%  
Current ratio x2.31.1 197.1%  
Inventory Days Days8491 92.3%  
Debtors Days Days11296 117.2%  
Net fixed assets Rs m127,516472,545 27.0%   
Share capital Rs m9053,561 25.4%   
"Free" reserves Rs m136,5170-   
Net worth Rs m137,4221,607,079 8.6%   
Long term debt Rs m66,417739,762 9.0%   
Total assets Rs m279,4943,306,317 8.5%  
Interest coverage x7.09.8 71.4%   
Debt to equity ratio x0.50.5 105.0%  
Sales to assets ratio x0.60.4 136.7%   
Return on assets %3.33.6 91.1%  
Return on equity %4.45.6 78.5%  
Return on capital %8.94.9 180.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m37,1320-   
CASH FLOW
From Operations Rs m16,660230,539 7.2%  
From Investments Rs m-32,825-81,689 40.2%  
From Financial Activity Rs m7,441-276,547 -2.7%  
Net Cashflow Rs m-8,724-127,697 6.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.22 Rs / USD

Compare LUPIN With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare LUPIN With: PROCTER & GAMBLE HEALTH  BIOCON   WOCKHARDT  DISHMAN PHARMA  IPCA LABS  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views On News

LUPIN Announces Quarterly Results (1QFY20); Net Profit Up 49.3% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, LUPIN has posted a net profit of Rs 3 bn (up 49.3% YoY). Sales on the other hand came in at Rs 44 bn (up 14.6% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of LUPIN for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of LUPIN. Also includes updates on the valuation of LUPIN.

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


Oct 18, 2019 (Close)

TRACK LUPIN

COMPARE LUPIN WITH

MARKET STATS